Warner Chilcott Calls Truce Over Birth Control Drug
Warner Chilcott announced the deal on Tuesday, revealing that Schering had decided to pay the pharmaceutical giant an undisclosed amount in order to put the infringement claims to rest.
“The terms of the agreement are confidential and subject to clearance by the Federal Trade Commission,” the company stated.
The move marks the end of a war that...
To view the full article, register now.